For rigorous in vitro and animal models, high-grade research SS-31 should present an HPLC purity percentage of ≥98.0%, verified via mass spectrometry with endotoxin levels below 0.1 EU/mg. PX1 Research delivers analytical-grade SS-31 backed by USA synthesis, lot-specific third-party HPLC/MS and LAL endotoxin testing, and fast same-day shipping M–F from CA and AZ fulfillment hubs.
For rigorous in vitro and animal models, high-grade research SS-31 should present an HPLC purity percentage of ≥98.0%, verified via mass spectrometry with endotoxin levels below 0.1 EU/mg. PX1 Research delivers analytical-grade SS-31 backed by USA synthesis, lot-specific third-party HPLC/MS and LAL endotoxin testing, and fast same-day shipping M–F from CA and AZ fulfillment hubs.
In analytical peptide chemistry, the optimal SS-31 purity percentage for controlled laboratory experiments is ≥98.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). Purity levels below 95.0% introduce truncated sequences, deletion peptides, and chemical artifacts that undermine data reproducibility in cellular assays.
Beyond raw HPLC purity, researchers must evaluate Net Peptide Content (NPC), counterion profiles (typically trifluoroacetate or acetate), and bacterial endotoxin activity. Lyophilized powders are not 100% active peptide by weight due to bound salts and residual moisture, making verified lot-specific analytical data essential before reconstitution.
PX1 Research synthesizes all material under strict quality systems, verifying sequence identity via Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or Electrospray Ionization Mass Spectrometry (ESI-MS). Every batch includes a downloadable Certificate of Analysis (COA) corresponding to the exact lot number on the vial, dispatching same-day M–F from facilities in California and Arizona.
When purchasing compounds for cellular or preclinical models, investigators frequently query what baseline purity threshold is necessary to prevent off-target effects. For SS-31 (a tetrapeptide synthetic analog researched for mitochondrial cardiolipin interaction), an RP-HPLC purity percentage of 98.0% or higher is considered the gold standard for publishable scientific literature.
Lesser purity grades (such as 90% or 95% technical grade) contain measurable concentrations of manufacturing byproducts. These byproducts typically include unreacted amino acid chains, side-chain protecting group adducts, and truncated sequences generated during solid-phase peptide synthesis (SPPS). In sensitive enzymatic or cell-viability assays, these impurities can compete for binding sites or induce unexpected cellular toxicity.
When you buy order 10 mg vials of SS-31 from PX1 Research, you receive material verified to meet or exceed the ≥98.0% threshold. This high baseline ensures that experimental outcomes reflect the direct biochemical activity of the intended sequence rather than background contamination.
A common point of confusion among laboratory buyers is the distinction between HPLC chromatographic purity and Net Peptide Content (NPC). The reported HPLC purity percentage reflects relative chromatographic peak integration: it measures what fraction of the UV-absorbing material in the sample corresponds to the target peptide peak relative to total integrated peaks at 214 nm or 220 nm.
Net Peptide Content, conversely, measures the actual mass fraction of target peptide relative to counterions, residual water, and non-peptide mass present in the lyophilized cake. Because synthetic peptides require TFA (trifluoroacetic acid) or acetic acid during purification and cleavage, the resulting lyophilized powder contains salt counterions bound to basic amine groups.
In a standard lyophilized vial containing 10 mg of total powder, the net peptide mass is generally between 70% and 85% (7.0 mg to 8.5 mg of pure peptide), with the remainder composed of trifluoroacetate or acetate salts and trace moisture. Researchers performing precise molar calculations must account for NPC alongside the HPLC purity percentage when preparing stock concentrations.
While RP-HPLC establishes chromatographic homogeneity and quantifies impurity levels, it cannot confirm that the principal peak has the correct chemical structure. Confirmation requires Mass Spectrometry (ESI-MS or MALDI-TOF) to measure the precise molecular weight of the synthesized molecule.
SS-31 (Elamipretide) possesses the amino acid sequence D-Arg-Dmt-Lys-Phe-NH2, where Dmt represents 2',6'-dimethyl-L-tyrosine. The theoretical monoisotopic molecular weight of this tetrapeptide is approximately 639.80 g/mol (or ~640.8 Da for the protonated [M+H]+ ion). Analytical testing must show a dominant mass-to-charge (m/z) peak that matches this theoretical mass within standard instrument error tolerances (typically ±0.5 Da).
A complete COA must display the actual mass spectrum graph alongside the calculated mass. If a vendor provides HPLC chromatograms without corresponding MS spectrum data, the identity of the target compound remains unverified. You can review full analytical dossiers in our complete catalog of research peptides.
During solid-phase synthesis and subsequent preparative HPLC purification, trifluoroacetic acid (TFA) is the standard mobile-phase additive used to achieve sharp peak separation. As a result, standard research-grade peptides exist as TFA salts, where positively charged basic residues (such as Lysine and Arginine in SS-31) form ionic bonds with trifluoroacetate anions.
For most in vitro and non-survival animal research, residual TFA salts at standard scientific concentrations do not interfere with study outcomes. However, in sensitive cell cultures or specific primary cell lines, elevated TFA levels can alter baseline pH or exert mild cytotoxic effects. In such cases, laboratories may require acetate salt conversions or strict limits on residual TFA content.
Karl Fischer titration or thermogravimetric analysis (TGA) is utilized to measure residual water content in the lyophilized cake, which typically ranges between 2% and 8%. Understanding these residual components allows researchers to correctly evaluate compound stability and storage parameters, as detailed in our comprehensive SS-31 research overview.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent pyrogens capable of stimulating immune responses at picogram concentrations. In cell culture, endotoxin contamination causes non-specific macrophage activation, cytokine release, and altered metabolic flux that invalidates experimental data.
Standard research-grade peptides should undergo rigorous Limulus Amebocyte Lysate (LAL) testing to quantify endotoxin activity. For high-grade laboratory applications, endotoxin levels should be verified at <0.1 EU/mg (Endotoxin Units per milligram) or <0.05 EU/mg for sensitive primary cell cultures.
PX1 Research screens batch lots using chromogenic LAL assays to ensure that endotoxin levels remain below strict operational limits. This screening prevents confounding inflammatory signaling when evaluating compounds in biological assays.
To ensure complete transparency, research teams should evaluate every COA using a systematic six-point inspection protocol:
1. Product Name & Lot Identification: Verify that the sequence, chemical formula, and lot number on the certificate precisely match the physical vial label.
2. RP-HPLC Purity Profile: Confirm a distinct, single major peak at the target retention time, with the main peak area integration reading ≥98.0%. Inspect baseline stability for minor impurity peaks.
3. Mass Spectrometry (MS) Data: Confirm that the observed m/z ratio matches the theoretical mass of SS-31 (monoisotopic ~639.8 Da / [M+H]+ ~640.8 Da).
4. Physical Appearance: Confirm the material is described as a uniform, white to off-white lyophilized powder free of visible particulate matter or discoloration.
5. Solubility and Appearance in Solution: Verify that the compound dissolves completely in sterile water or phosphate-buffered saline (PBS) to yield a clear, colorless solution.
6. Endotoxin Quantitation: Check the reported LAL test value to confirm it meets the target limit (<0.1 EU/mg).
When choosing a supplier for critical research reagents, rely on quantifiable analytical parameters rather than marketing claims. The table below outlines key standard metrics required for high-integrity experimental work:
- Target Purity Percentage: Minimum 98.0% via RP-HPLC peak integration at 214 nm / 220 nm.
- Identity Confirmation: ESI-MS or MALDI-TOF mass spectra supplied per batch lot matching calculated molecular weight.
- Endotoxin Threshold: Tested via LAL assay; verified <0.1 EU/mg for preclinical cell models.
- Net Peptide Content Data: CHN elemental analysis or quantitative amino acid analysis (AAA) available upon request.
- Lot Traceability: Direct linkage between physical vial batch code and downloadable analytical report.
- Shipping and Storage Protocol: Lyophilized format shipped temperature-stable with recommended -20°C long-term storage instructions.
To inspect our full analytical documentation or request bulk lot reservations, visit our wholesale peptide supply portal.
Purchasing research compounds from unverified vendors risks introducing untested impurities into your workflow. Researchers should watch for several clear red flags:
Generic or Shared COAs: Vendors who present a single COA across multiple batches or omit specific lot numbers are not providing true batch-level verification.
Cropped or Absent Chromatograms: A text report listing '99% purity' without providing the underlying HPLC chromatogram and mass spectrum graph obscures actual data.
Unusually Low Mass or Gummy Appearance: SS-31 should form a stable, white lyophilized cake. Gummy, yellowed, or collapsed powders indicate excess moisture, solvent retention, or degradation.
Lack of Endotoxin Protocol: Suppliers who fail to perform LAL testing cannot guarantee that their material is free from inflammatory LPS artifacts.
No Domestic Logistics Control: Overseas drop-shipping operations lack real-time temperature control during transit and cannot offer consistent delivery timelines.
In mitochondrial physiology and cellular bioenergetics research, SS-31 is often evaluated alongside other mitochondrial-targeted compounds and metabolic regulators.
For example, researchers studying mitochondrial-derived peptides frequently cross-reference data with MOTS-c research peptides, which modulate nuclear gene expression in response to metabolic stress. Similarly, investigations into intracellular NAD+ pools and oxidative phosphorylation often pair peptide models with cofactors from our laboratory research catalog.
Maintaining consistent high-purity standards across all reagents in a comparative panel is essential to isolate compound-specific cellular effects.
PX1 Research provides laboratory-grade SS-31 formulated specifically for in vitro and preclinical research applications. Each unit is supplied as a vacuum-sealed, lyophilized powder in protective glass vials engineered to maintain long-term peptide stability.
Orders placed before 2:00 PM PST Monday through Friday ship same-day from our domestic fulfillment centers in California and Arizona. Every package features tracked, expedited domestic delivery to ensure minimal thermal exposure during transit.
Every batch of SS-31 is linked to an accessible, downloadable COA showing lot-specific RP-HPLC, Mass Spectrometry, and LAL endotoxin analytical results. Our technical support team—staffed by specialists familiar with peptide chemistry—is available to assist with analytical inquiries or bulk specifications.
To review current batch availability and secure verified material for your laboratory, order SS-31 10 mg vials online directly from PX1 Research.
What is the recommended SS-31 purity percentage for cell culture research?
For cell culture and sensitive in vitro models, SS-31 should feature an HPLC purity percentage of ≥98.0%. Lower purity levels introduce truncated synthesis sequences and counterion impurities that can induce cell toxicity or confound experimental results.
How does HPLC purity differ from net peptide content in SS-31 vials?
HPLC purity measures the relative percentage of the target peptide peak relative to peptide impurities. Net peptide content (NPC) measures the actual percentage of target peptide mass in the lyophilized powder relative to bound counterions (such as TFA or acetate) and residual moisture.
What is the theoretical molecular weight of SS-31 on a mass spectrum?
SS-31 (Elamipretide) has a calculated monoisotopic molecular mass of approximately 639.80 g/mol. On an ESI-MS spectrum, it typically appears as a protonated single ion peak [M+H]+ at approximately 640.8 m/z.
Why is endotoxin testing important for SS-31 research peptides?
Bacterial endotoxins (LPS) trigger inflammatory responses in cell cultures and animal tissue models. Verifying an endotoxin level below 0.1 EU/mg ensures that cellular activation is caused by SS-31 rather than bacterial contaminants.
Are PX1 Research peptides supplied with a lot-specific COA?
Yes. Every batch of SS-31 supplied by PX1 Research includes a downloadable lot-specific Certificate of Analysis featuring complete RP-HPLC chromatograms, Mass Spectrometry sequence verification, and LAL endotoxin test results.
What counterion is typically present in research-grade SS-31?
Research-grade SS-31 is standardly synthesized as a trifluoroacetate (TFA) salt resulting from mobile phase purification. Acetate salt formats are also available for specialized primary cell assays where TFA sensitivity is a concern.
How fast does PX1 Research dispatch SS-31 orders?
Orders placed before 2:00 PM PST Monday through Friday dispatch the same day from our CA or AZ fulfillment hubs via tracked domestic shipping.
How should lyophilized SS-31 be stored upon receipt?
Lyophilized SS-31 powder should be stored at -20°C in a dry environment upon receipt. Reconstituted stock solutions should be aliquoted and kept at -80°C to avoid repeated freeze-thaw cycles.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.